Strategic question
Which APAC Digital Health ventures can help us drive HPV awareness, cervical cancer action and immuno-oncology innovation?
How Galen Growth helped
From market signal to decision-ready evidence
Using HealthTech Alpha and on-the-ground APAC expertise, we mapped the Digital Health landscape across 10 markets, curated a shortlist of startups and investors, and designed engagement events to catalyse direct partnership conversations.
Outcomes
Moved the franchise from passive scouting to active ecosystem engagement with decision-ready partners.
Decision enabled: Enabled the client to open structured partnership conversations with high-potential APAC startups and investors.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?